<SEC-DOCUMENT>0001213900-17-002475-index.html : 20170316 <SEC-HEADER>0001213900-17-002475.hdr.sgml : 20170316 <ACCEPTANCE-DATETIME>20170316165025 ACCESSION NUMBER: 0001213900-17-002475 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20170316 DATE AS OF CHANGE: 20170316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-216748 FILM NUMBER: 17695188 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3875 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>fs32017_actiniumpharma.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: fs32017_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.2 <SEQUENCE>2 <FILENAME>fs32017ex1ii_actiniumpharma.htm <DESCRIPTION>FORM OF UNDERWRITING AGREEMENT <TEXT> Document 2 - file: fs32017ex1ii_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>fs32017ex5i_actiniumpharma.htm <DESCRIPTION>OPINION OF THE MATT LAW FIRM, PLLC <TEXT> Document 3 - file: fs32017ex5i_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>fs32017ex23i_actiniumpharma.htm <DESCRIPTION>CONSENT OF GBH CPAS, PC <TEXT> Document 4 - file: fs32017ex23i_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: image_003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex5i_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: ex5i_001.jpg
</DOCUMENT> </SEC-DOCUMENT>